摘要 |
The present invention relates to novel Fused Tricyclic SiIyI Compounds of Formula (I): and pharmaceutically acceptable salts thereof, wherein A, B, C, D, M1, X1 and X2 are as defined herein. The present invention also relates to compositions comprising at least one Fused Tricyclic Silyl Compound, and methods of using the Fused Tricyclic Silyl Compounds for treating or preventing HCV infection in a patient. |
申请人 |
SCHERING CORPORATION;NAIR, ANILKUMAR GOPINADHAN;KEERTIKAR, KERRY, M.;KIM, SEONG HEON;KOZLOWSKI, JOSEPH, A.;ROSENBLUM, STUART;SELYUTIN, OLEG, B.;WONG, MICHAEL;YU, WENSHENG;ZENG, QINGBEI |
发明人 |
NAIR, ANILKUMAR GOPINADHAN;KEERTIKAR, KERRY, M.;KIM, SEONG HEON;KOZLOWSKI, JOSEPH, A.;ROSENBLUM, STUART;SELYUTIN, OLEG, B.;WONG, MICHAEL;YU, WENSHENG;ZENG, QINGBEI |